Lanoxin

Medicinal product

(Invented) name

Lanoxin

Active substance (s)

Digoksinas

Strength

250 µg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

C01AA05, Digoxin

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2022-07-25

Date of renewal

Documents

1709_Lanoxin_2025-02-26_K.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Digoksinas	250 µg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
109068	95174	1095174	lizdinė plokštelė	N30		Receptinis	LT/L/22/1709/001	Tiekiama	-	-	No	-	-	Download
109069	95175	1095175	lizdinė plokštelė	N120		Receptinis	LT/L/22/1709/002	Netiekiama	-	2025-03-18	No	-	-	Download
116771	102874	1102874	lizdinė plokštelė	N90		Receptinis	LT/L/22/1709/003	Netiekiama	2025-06-02	2025-10-01	Yes	2025-07-01	2025-10-01	Download

Stadijos

Data	Stadija
2022-07-25	Registruotas